191 related articles for article (PubMed ID: 36564040)
1. Autoimmune haemolytic anaemia and immune thrombocytopenia following SARS-CoV-2 and non-SARS-CoV-2 vaccination: 32 Years of passive surveillance data.
Jacobs JW; Booth GS; Guarente J; Schlafer D; Zheng L; Adkins BD
Br J Haematol; 2023 Apr; 201(2):227-233. PubMed ID: 36564040
[TBL] [Abstract][Full Text] [Related]
2. Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination.
Jacobs JW; Booth GS; Adkins BD
Ann Hematol; 2023 Apr; 102(4):955-959. PubMed ID: 36795118
[TBL] [Abstract][Full Text] [Related]
3. Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia.
Ruzicka M; Wurm S; Lindner L; Dreyling M; von Bergwelt-Baildon M; Boeck S; Giessen-Jung C; Milani V; Stemmler JH; Subklewe M; Weigert O; Spiekermann K
Infection; 2023 Feb; 51(1):231-238. PubMed ID: 36195695
[TBL] [Abstract][Full Text] [Related]
4. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).
Welsh KJ; Baumblatt J; Chege W; Goud R; Nair N
Vaccine; 2021 Jun; 39(25):3329-3332. PubMed ID: 34006408
[TBL] [Abstract][Full Text] [Related]
5. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH
J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
Lee EJ; Beltrami-Moreira M; Al-Samkari H; Cuker A; DiRaimo J; Gernsheimer T; Kruse A; Kessler C; Kruse C; Leavitt AD; Lee AI; Liebman HA; Newland AC; Ray AE; Tarantino MD; Thachil J; Kuter DJ; Cines DB; Bussel JB
Blood; 2022 Mar; 139(10):1564-1574. PubMed ID: 34587251
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and Immune-Mediated RBC Destruction.
Jacobs JW; Booth GS
Am J Clin Pathol; 2022 Jun; 157(6):844-851. PubMed ID: 34919640
[TBL] [Abstract][Full Text] [Related]
8. Vaccine-associated thrombocytopenia.
Gan G; Liu H; Liang Z; Zhang G; Liu X; Ma L
Thromb Res; 2022 Dec; 220():12-20. PubMed ID: 36265409
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics in immune thrombocytopenia patients after COVID-19 vaccination.
Feng Y; Quan Y; Cassady K; Zou Z; Gao Y; Zhang X
Hum Vaccin Immunother; 2022 Nov; 18(6):2119043. PubMed ID: 36069667
[TBL] [Abstract][Full Text] [Related]
10. Increased incidence of immune thrombocytopenia (ITP) in 2021 correlating with the ongoing vaccination campaign against COVID-19 in a tertiary center - A monocentric analysis.
Schaefers C; Paulsen FO; Frenzel C; Weisel K; Bokemeyer C; Seidel C
Br J Haematol; 2023 Apr; 201(2):222-226. PubMed ID: 36793157
[TBL] [Abstract][Full Text] [Related]
11. Seroconversion to mRNA SARS-CoV-2 vaccines in patients with autoimmune cytopenias and bone marrow failures.
Fattizzo B; Bortolotti M; Giannotta JA; Consonni D; Cantoni S; Barcellini W
Sci Rep; 2022 May; 12(1):7743. PubMed ID: 35546175
[TBL] [Abstract][Full Text] [Related]
12. Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group.
González-López TJ; Bárez A; Bernardo-Gutiérrez A; Bernat S; Canaro-Hirnyk M; Entrena-Ureña L; Fernández-Fuertes F; Guinea de Castro JM; Jiménez-Bárcenas R; Pascual-Izquierdo C; Sánchez-González B; Jarque I
Infect Dis Ther; 2023 Feb; 12(2):303-315. PubMed ID: 36520323
[TBL] [Abstract][Full Text] [Related]
13. Vaccination-associated immune thrombocytopenia possibly due to ChAdOx1 nCoV-19 (Covishield) coronavirus vaccine.
Sivaramakrishnan P; Mishra M
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35354570
[TBL] [Abstract][Full Text] [Related]
14. Real-world, single-center experience of SARS-CoV-2 vaccination in immune thrombocytopenia.
Woolley P; Tailor A; Shah R; Westwood JP; Scully M
J Thromb Haemost; 2022 Jun; 20(6):1476-1484. PubMed ID: 35313390
[TBL] [Abstract][Full Text] [Related]
15. Successful Treatment of Immune Thrombocytopenic Purpura with Intracranial Hemorrhaging and Duodenal Bleeding Following SARS-CoV-2 Vaccination.
Baba Y; Sakai H; Kabasawa N; Harada H
Intern Med; 2022 Jun; 61(12):1891-1895. PubMed ID: 35400701
[TBL] [Abstract][Full Text] [Related]
16. Vigilance regarding immune thrombocytopenic purpura after COVID-19 vaccine.
Saudagar V; Patil S; Goh S; Pothiawala S
Ir J Med Sci; 2022 Apr; 191(2):919-920. PubMed ID: 33788135
[TBL] [Abstract][Full Text] [Related]
17. A narrative review of anti-SARS-CoV-2 vaccines and immune thrombocytopenia: be aware, but reassured.
Beltrami-Moreira M; Bussel JB
Clin Adv Hematol Oncol; 2022 Sep; 20(9):572-578. PubMed ID: 36125949
[TBL] [Abstract][Full Text] [Related]
18. Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection.
Chiao EY; Engels EA; Kramer JR; Pietz K; Henderson L; Giordano TP; Landgren O
Arch Intern Med; 2009 Feb; 169(4):357-63. PubMed ID: 19237719
[TBL] [Abstract][Full Text] [Related]
19. Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.
Gordon SF; Clothier HJ; Morgan H; Buttery JP; Phuong LK; Monagle P; Chunilal S; Wood EM; Tran H; Szer J; Crawford NW;
Vaccine; 2021 Nov; 39(48):7052-7057. PubMed ID: 34756770
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.
Saluja P; Gautam N; Yadala S; Venkata AN
Thromb Res; 2022 Jun; 214():115-121. PubMed ID: 35533526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
